Published online August 31, 2005
PEDIATRICS Vol. 116 No. 3 September 2005, pp. 696-702 (doi:10.1542/10.1542/peds.2004-2421)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Glasgow, T. S. Articles by Byington, C. L. Search for Related Content PubMed PubMed Citation Articles by Glasgow, T. S. Articles by Byington, C. L. Related Collections Infectious Disease & Immunity Social Bookmarking                         What's this?

Association of Intrapartum Antibiotic Exposure and Late-Onset Serious Bacterial Infections in Infants

Tiffany S. Glasgow, MD^*, Paul C. Young, MD^*, Jordan Wallin, BS^*, Carolyn Kwok, MD^*, Greg Stoddard, MPH, Sean Firth, PhD, MPH^*, Matthew Samore, MD^, and Carrie L. Byington, MD^*,||

^* Divisions of General Pediatrics
Internal Medicine
Infectious Diseases
^|| Pediatric Infectious Diseases, University of Utah, Salt Lake City, Utah

Objective. Recommendations to prevent vertical transmission of group B Streptococcus (GBS) infections have resulted in many women's receiving antibiotics during labor with an associated reduction in early-onset GBS infections in their newborn infants. However, a potential relationship of intrapartum antibiotics (IPA) to the occurrence of late-onset (7–90 days) serious bacterial infections (SBIs) in term infants has not been reported. The objectives of this study were to determine whether infants with late-onset SBI were more likely than healthy control infants to have been exposed to IPA and whether there was a greater likelihood of antibiotic resistance in bacteria that were isolated from infants who had an SBI and had been exposed to IPA compared with those who had not.

Methods. We used a case-control design to study the first objective. Cases were previously healthy full-term infants who were hospitalized for late-onset SBI between the ages of 7 and 90 days. Control subjects were healthy full-term infants who were known not to have an SBI in their first 90 days. Cases and control subjects were matched for hospital of delivery. In the second part of the study, rates of antibiotic resistance of bacteria that were isolated from infected infants were compared for those who had and had not been exposed to IPA.

Results. Ninety case infants and 92 control subjects were studied. Considering all types of IPA, more case (41%) than control infants (27%) had been exposed to IPA (adjusted odds ratio [OR]: 1.96; 95% confidence interval [CI]: 1.05–3.66), after controlling for hospital of delivery. The association was stronger when IPA was with broad-spectrum antibiotics (adjusted OR: 4.95; 95% CI: 2.04–11.98), after controlling for hospital of delivery, penicillin IPA, maternal chorioamnionitis, and breastfeeding. Bacteria that were isolated from infected infants who had been exposed to IPA were more likely to exhibit ampicillin resistance (adjusted OR: 5.7; 95% CI: 2.3–14.3), after controlling for hospital of delivery, but not to other antibiotics that are commonly used to treat SBI in infants.

Conclusions. After adjusting for potential confounders, infants with late-onset SBI were more likely to have been exposed to IPA than noninfected control infants. Pathogens that cause late-onset SBI were more likely to be resistant to ampicillin when the infant had been exposed to intrapartum antibiotics.

---

Key Words: intrapartum antibiotics • serious bacterial infection • term infant • antibiotic resistance • group B Streptococcus

Abbreviations: GBS, group B Streptococcus • SBI, serious bacterial infection • IPA, intrapartum antibiotic • PCMC, Primary Children's Medical Center • OR, odds ratio • UTI, urinary tract infection • CI, confidence interval

---

Accepted Dec 30, 2004.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Kafulafula, A. Mwatha, Y. Q. Chen, S. Aboud, F. Martinson, I. Hoffman, W. Fawzi, J. S. Read, M. Valentine, K. Mwinga, et al. Intrapartum Antibiotic Exposure and Early Neonatal, Morbidity, and Mortality in Africa Pediatrics, July 1, 2009; 124(1): e137 - e144. [Abstract] [Full Text] [PDF]

				G. Konrad and A. Katz Epidemiology of early-onset neonatal group B streptococcal infection: Implications for screening Can Fam Physician, June 1, 2007; 53(6): 1054 - 1055. [Abstract] [Full Text] [PDF]

				G. Konrad, S. Hauch, and C. Pylypjuk Prevention of neonatal group B streptococcal infection: Approaches of physicians in Winnipeg, Man Can Fam Physician, February 1, 2007; 53(2): 289 - 290. [Abstract] [Full Text] [PDF]

				R. K. Edwards and P. Duff Intrapartum Antibiotic Prophylaxis: Making an Evidence-Based Selection Pediatrics, January 1, 2006; 117(1): 255 - 256. [Full Text] [PDF]

				T. S. Glasgow, P. C. Young, and C. L. Byington Intrapartum Antibiotic Prophylaxis: Making an Evidence-Based Selection: In Reply Pediatrics, January 1, 2006; 117(1): 256 - 257. [Full Text] [PDF]